Diaceutics PLC (DXRX) — Working Capital to Net Assets Ratio
Diaceutics PLC (DXRX) has a Working Capital to Net Assets ratio of 51.4% as of December 2025. Working capital of GBX20.81 Million (current assets of GBX29.36 Million minus current liabilities of GBX8.55 Million) is measured against net assets of GBX40.48 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See operational self-sufficiency of Diaceutics PLC to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Diaceutics PLC Working Capital to Net Assets (2015–2025)
This chart shows how Diaceutics PLC's Working Capital to Net Assets ratio has evolved across 11 annual periods from 2015 to 2025. As of December 2025, the ratio stands at 51.4%, reflecting working capital of GBX20.81 Million against net assets of GBX40.48 Million GBX. For the complete balance sheet picture, see DXRX asset base.
Annual Working Capital to Net Assets for Diaceutics PLC (2015–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Diaceutics PLC from 2015 to 2025, covering 11 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Explore DXRX long-term investments to assets to see how much of total assets are deployed in long-term investments.
| Year | WC/NA Ratio | Working Capital (GBX) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 51.4% | GBX20.81 Million | GBX40.48 Million | GBX29.36 Million | GBX8.55 Million | ▼ -3.2 pp |
| 2024 | 54.6% | GBX21.76 Million | GBX39.86 Million | GBX29.53 Million | GBX7.76 Million | ▼ -3.4 pp |
| 2023 | 58.0% | GBX23.66 Million | GBX40.79 Million | GBX28.04 Million | GBX4.38 Million | ▼ -5.8 pp |
| 2022 | 63.8% | GBX27.14 Million | GBX42.51 Million | GBX30.90 Million | GBX3.75 Million | ▼ -3.6 pp |
| 2021 | 67.5% | GBX27.43 Million | GBX40.65 Million | GBX30.06 Million | GBX2.63 Million | ▼ -8.8 pp |
| 2020 | 76.3% | GBX30.70 Million | GBX40.24 Million | GBX33.62 Million | GBX2.92 Million | ▼ -4.1 pp |
| 2019 | 80.4% | GBX16.18 Million | GBX20.13 Million | GBX18.42 Million | GBX2.24 Million | ▼ -15.8 pp |
| 2018 | 96.2% | GBX2.53 Million | GBX2.63 Million | GBX6.46 Million | GBX3.93 Million | ▼ -51.1 pp |
| 2017 | 147.2% | GBX2.76 Million | GBX1.88 Million | GBX4.83 Million | GBX2.06 Million | ▼ -31.5 pp |
| 2016 | 178.7% | GBX1.81 Million | GBX1.01 Million | GBX3.23 Million | GBX1.42 Million | ▼ -59.1 pp |
| 2015 | 237.8% | GBX396.50K | GBX166.71K | GBX1.32 Million | GBX927.33K | — |